457 related articles for article (PubMed ID: 23281407)
1. Adaptive immunity in atherogenesis: new insights and therapeutic approaches.
Lichtman AH; Binder CJ; Tsimikas S; Witztum JL
J Clin Invest; 2013 Jan; 123(1):27-36. PubMed ID: 23281407
[TBL] [Abstract][Full Text] [Related]
2. The influence of innate and adaptive immune responses on atherosclerosis.
Witztum JL; Lichtman AH
Annu Rev Pathol; 2014; 9():73-102. PubMed ID: 23937439
[TBL] [Abstract][Full Text] [Related]
3. How Oxidized Low-Density Lipoprotein Activates Inflammatory Responses.
Rhoads JP; Major AS
Crit Rev Immunol; 2018; 38(4):333-342. PubMed ID: 30806246
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein B100 autoimmunity and atherosclerosis - disease mechanisms and therapeutic potential.
Nilsson J; Björkbacka H; Fredrikson GN
Curr Opin Lipidol; 2012 Oct; 23(5):422-8. PubMed ID: 22814703
[TBL] [Abstract][Full Text] [Related]
5. Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans.
Chou MY; Fogelstrand L; Hartvigsen K; Hansen LF; Woelkers D; Shaw PX; Choi J; Perkmann T; Bäckhed F; Miller YI; Hörkkö S; Corr M; Witztum JL; Binder CJ
J Clin Invest; 2009 May; 119(5):1335-49. PubMed ID: 19363291
[TBL] [Abstract][Full Text] [Related]
6. Immunity in Atherosclerosis: Focusing on T and B Cells.
Poznyak AV; Bezsonov EE; Popkova TV; Starodubova AV; Orekhov AN
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445084
[TBL] [Abstract][Full Text] [Related]
7. Oxidation-specific epitopes as targets for biotheranostic applications in humans: biomarkers, molecular imaging and therapeutics.
Miller YI; Tsimikas S
Curr Opin Lipidol; 2013 Oct; 24(5):426-37. PubMed ID: 23995232
[TBL] [Abstract][Full Text] [Related]
8. β2-glycoprotein I and oxidative inflammation in early atherogenesis: a progression from innate to adaptive immunity?
Matsuura E; Lopez LR; Shoenfeld Y; Ames PR
Autoimmun Rev; 2012 Dec; 12(2):241-9. PubMed ID: 22569463
[TBL] [Abstract][Full Text] [Related]
9. Immune effector mechanisms implicated in atherosclerosis: from mice to humans.
Libby P; Lichtman AH; Hansson GK
Immunity; 2013 Jun; 38(6):1092-104. PubMed ID: 23809160
[TBL] [Abstract][Full Text] [Related]
10. Promise of immune modulation to inhibit atherogenesis.
Binder CJ; Hartvigsen K; Witztum JL
J Am Coll Cardiol; 2007 Aug; 50(6):547-50. PubMed ID: 17678739
[No Abstract] [Full Text] [Related]
11. Experimental immunotherapeutic approaches for atherosclerosis.
Amir S; Binder CJ
Clin Immunol; 2010 Jan; 134(1):66-79. PubMed ID: 19666239
[TBL] [Abstract][Full Text] [Related]
12. Malondialdehyde Epitopes as Targets of Immunity and the Implications for Atherosclerosis.
Papac-Milicevic N; Busch CJ; Binder CJ
Adv Immunol; 2016; 131():1-59. PubMed ID: 27235680
[TBL] [Abstract][Full Text] [Related]
13. Immune-mediated mechanisms in atherosclerosis: prevention and treatment of clinical manifestations.
Niessner A; Goronzy JJ; Weyand CM
Curr Pharm Des; 2007; 13(36):3701-10. PubMed ID: 18220809
[TBL] [Abstract][Full Text] [Related]
14. Changes in immune responses to oxidized LDL epitopes during aging in hypercholesterolemic apoE(-/-) mice.
Dimayuga PC; Zhao X; Yano J; Chyu KY
Am J Physiol Regul Integr Comp Physiol; 2006 Dec; 291(6):R1644-50. PubMed ID: 16825416
[TBL] [Abstract][Full Text] [Related]
15. [Immune cells in atherosclerosis--good or bad?].
Klingenberg R; Matter CM; Lüscher TF
Praxis (Bern 1994); 2016 Apr; 105(8):437-44. PubMed ID: 27078727
[TBL] [Abstract][Full Text] [Related]
16. Innate immune recognition receptors and damage-associated molecular patterns in plaque inflammation.
Lundberg AM; Yan ZQ
Curr Opin Lipidol; 2011 Oct; 22(5):343-9. PubMed ID: 21881501
[TBL] [Abstract][Full Text] [Related]
17. Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis.
van Puijvelde GH; Hauer AD; de Vos P; van den Heuvel R; van Herwijnen MJ; van der Zee R; van Eden W; van Berkel TJ; Kuiper J
Circulation; 2006 Oct; 114(18):1968-76. PubMed ID: 17060383
[TBL] [Abstract][Full Text] [Related]
18. [Anti-inflammatory and immune modulation therapy against atherosclerosis].
Yamashita T; Hirata K
Nihon Rinsho; 2011 Jan; 69(1):168-72. PubMed ID: 21226279
[TBL] [Abstract][Full Text] [Related]
19. Anti-Inflammatory Therapy for Atherosclerosis: Focusing on Cytokines.
Poznyak AV; Bharadwaj D; Prasad G; Grechko AV; Sazonova MA; Orekhov AN
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209109
[TBL] [Abstract][Full Text] [Related]
20. The role of immune cells in different stages of atherosclerosis.
He C; Kim HI; Park J; Guo J; Huang W
Int J Med Sci; 2024; 21(6):1129-1143. PubMed ID: 38774746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
